Natera (NASDAQ:NTRA) Receives Buy Rating from Canaccord Genuity Group
Canaccord Genuity Group reissued their buy rating on shares of Natera (NASDAQ:NTRA – Free Report) in a research note released on Wednesday,Benzinga reports. Canaccord Genuity Group currently has a $180.00 price target on the medical research company’s stock. Other equities analysts also recently issued reports about the stock. Sanford C. Bernstein increased their price objective […]
Canaccord Genuity Group reissued their buy rating on shares of Natera (NASDAQ:NTRA – Free Report) in a research note released on Wednesday,Benzinga reports. Canaccord Genuity Group currently has a $180.00 price target on the medical research company’s stock. Other equities analysts also recently issued reports about the stock. Sanford C. Bernstein increased their price objective […]
